TNFSF13 and plasma cell myeloma: Furthermore, following 01A treatment, APRIL-induced expression of genes involved in immunosuppression, i.e., PD-1, transforming growth factor beta (TGF-β), and interleukin 10 (IL-10), is decreased in multiple myeloma cells [28,92,127].